Why InterStim^® Therapy for Urinary Control?

Patients are dissatisfied with drug therapy.

Study shows only 15% of patients remain on drug therapy through the first year*

• Effective urinary control via sacral nerve stimulation
• Proven efficacy in patients for whom more conventional therapy has been unsatisfactory
• Minimally invasive screening test and implant procedure
• More than 25,000 patients have received InterStim Therapy worldwide since FDA approval in 1997

References

*Adapted from the 2002 Gallup Study of the Market for Prescription Incontinence Medication.  Princeton, NJ: Multi-sponsor Survey, Inc. 2002.

©Medtronic, Inc. 2008                                                   • Contact Medtronic • Privacy Statement • Terms of Use • Site Map